Paul Hastings LLP, a leading global law firm, announced today that the firm represented Cowen and Company, a diversified financial services firm, as placement and exchange agent in connection with the issuance of $75.0 million aggregate principal amount of 5.875% senior notes due 2017 issued by Smith & Wesson Holding Corporation in exchange for approximately $42.8 million of the company’s 9.50% senior notes due 2016 from existing holders of such notes and the purchase by certain of such holders of additional new notes for cash. The firm is also representing Cowen and Company as dealer manager in connection with the company’s cash tender offer for certain of the company’s outstanding common stock.

More >>

Davis Polk is advising Delonex Energy Limited in connection with a $600 million investment from an investment group led by an affiliate of Warburg Pincus LLC.

More >>

Davis Polk is advising Grupo Financiero Santander México, S.A.B. de C.V. in connection with the Ps.643 million acquisition by its subsidiary, Banco Santander (México), S.A., Institución de Banca Múltiple, of ING Hipotecaria, S.A. de C.V., Sociedad Financiera de Objeto Múltiple, Entidad No Regulada, a subsidiary of ING Group. The transaction, which is subject to customary regulatory approvals, is expected to close in the second half of 2013.

More >>

Davis Polk advised affiliates of each of J.P. Morgan Securities LLC and Barclays Capital Inc. in connection with the execution of forward sale agreements on approximately 29.6 million shares of Thermo Fisher Scientific Inc.’s common stock (NYSE: TMO) in connection with an SEC-registered offering of an equal number of shares. The approximately 29.6 million shares include approximately 3.9 million shares purchased by the underwriters pursuant to their over-allotment option. In connection with the forward sale agreements, J.P. Morgan Securities LLC and Barclays Capital Inc., each as agent for its respective affiliate, borrowed an aggregate of approximately 29.6 million shares of Thermo Fisher Scientific Inc.’s common stock (approximately 25.7 million shares, in the aggregate, in connection with base forward sale agreements and 3.9 million shares, in the aggregate, in connection with additional forward sale agreements executed in connection with the exercise by the underwriters of their over-allotment option) from third parties and sold these shares to the underwriters. The net proceeds of the offering (assuming physical settlement of the forward sale agreements at the initial forward sale price) are expected to be approximately $2.46 billion.

More >>

As reported widely in the press, Willkie client Rockwood Holdings, Inc. announced on June 16 that it entered into a definitive agreement to sell CeramTec, its advanced ceramics business, to Cinven, a European private equity firm, for €1.49 billion (approx. $1.98 billion). The transaction is expected to close during the third quarter of 2013 upon certain regulatory approvals, including EU competition clearance.

More >>